NPPA fixes price of 84 formulations, revises 1
New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 84 formulations and has revised the retail price of 1 formulation under the Drugs (Prices Control) Order, 2013.
The price fixation is based on the decision of the 96th and 97th Authority meetings.
Out of 84 formulations, the authority has fixed the retail prices of 40 formulations which are fixed dose combinations (FDCs) of 2 molecules Linagliptin and Sitagliptin with metformin. The two drugs in question are soon going to become off-patent in July and the price authority has already fixed the price of their combination with the other popular drug metformin that is already under price control.
Read also: NPPA fixes retail prices of Linagliptin, Sitagliptin FDCs, Details
Apart from these 40 formulations, the authority has fixed retail prices of another 44 formulations ie., diabetes drug, underactive thyroid drug, heart ailment drug, Gastrointestinal drug, cough, painkiller etc.
This comes in exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 701(E) dated 10th March, 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
1. | Glimepiride and Metformin Hydrochloride sustained release tablets | Each uncoated bilayer tablet contains: Glimepiride IP 2mg Metformin Hydrochloride IP 500mg (As sustained release) | 1 Tablet | M/s Indu Drugs Private Limited / M/s. Maxbien Pharma Private Limited | 9.55 |
2. | Glimepiride and Metformin Hydrochloride sustained release tablets | Each uncoated bilayer tablet contains: Glimepiride IP 1mg Metformin Hydrochloride IP 500mg (As sustained release) | 1 Tablet | M/s Indu Drugs Private Limited / M/s. Maxbien Pharma Private Limited | 6.78 |
3. | Gastro-Resistant Omeprazole and Domperidone Sustained Release Capsules | Each hard gelatin capsule contains: Omeprazole IP 20mg (as gastro-resistant pellets) Domperidone IP 30mg (as sustained release pellets) | 1 Capsule | M/s Indu Drugs Private Limited / M/s. Ma Lara Healthcare Pvt. Ltd. | 9.53 |
4. | Gastro-Resistant Pantoprazole and Domperidone Sustained Release Capsules | Each hard gelatin capsule contains: Pantoprazole Sodium IP eq. to Pantoprazole 40mg (as gastro-resistant pellets) Domperidone IP 30mg (as sustained release pellets) | 1 Capsule | M/s Indu Drugs Private Limited / M/s. Ma Lara Healthcare Pvt. Ltd. | 9.21 |
5. | Gastro-Resistant Rabeprazole and Domperidone Sustained Release Capsules | Each hard gelatin capsule contains: Rabeprazole Sodium IP 20mg (as gastro-resistant pellets) Domperidone IP 30mg (as sustained release pellets) | 1 Capsule | M/s Indu Drugs Private Limited / M/s. Ma Lara Healthcare Pvt. Ltd. | 9.67 |
6. | Gastro-Resistant Esomeprazole and Domperidone Sustained Release Capsules | Each hard gelatin capsule contains: Esomeprazole Magnesium Trihydrate IP eq. to Esomeprazole 40mg (As gastro-resistant pellets) Domperidone IP 30mg (As Sustained Release pellets) | 1 Capsule | M/s Indu Drugs Private Limited / M/s. Ma Lara Healthcare Pvt. Ltd. | 10.17 |
7. | Thyroxine Sodium Tablets | Each uncoated tablet contains: Thyroxine Sodium IP eq. to anhydrous Thyroxine Sodium 200mcg (Synthetic Thyroid Hormone) | 1 Tablet | M/s Abbott India Ltd. | 1.98 |
8. | Atorvastatin & Ezetimibe Tablets | Each film coated tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 10mg Ezetimibe IP 10mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. /M/s German Remedies Pharmaceuticals Private Limited | 16.23 |
9. | Atorvastatin & Clopidogrel Tablets | Each Uncoated Bilayered tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 10mg Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd. /M/s German Remedies Pharmaceuticals Private Limited | 11.62 |
10. | Dextromethorphan hydrobromide, Chlorpheniramine Maleate & Phenylephrine Hydrochloride Syrup | Each 5 ml contains: Dextromethorphan hydrobromide IP 10mg Chlorpheniramine Maleate IP 2mg Phenylephrine Hydrochloride IP 5mg | 1 ML | M/s Akums Drugs & Pharmaceuticals Ltd. /M/s German Remedies Pharmaceuticals Private Limited | 0.86 |
11. | Atorvastatin, Clopidogrel & Aspirin Capsules | Each hard gelatin capsule contains: Atorvastatin Calcium IP eq. to Atorvastatin 10mg (As film coated tablet IP) Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg Aspirin IP 75mg (As Gastro- Resistant Tablet IP) | 1 Capsule | M/s Safetab Life Science / M/s Ajanta Pharma Ltd. | 4.68 |
12. | Atorvastatin, Clopidogrel & Aspirin Capsules | Each hard gelatin capsule contains: Atorvastatin Calcium IP eq. to Atorvastatin 20mg (As film coated tablet IP) Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg Aspirin IP 75mg (As Gastro- Resistant Tablet IP) | 1 Capsule | M/s Safetab Life Science / M/s Ajanta Pharma Ltd. | 6.32 |
13. | Paracetamol Infusion IP | Each 100ml contains: Paracetamol IP 1000mg water for Injection IP | 1 ML | M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Mankind Life Sciences Pvt. Ltd. | 2.88 |
14. | Norethisterone Acetate controlled release Tablets | Each film coated controlled release tablet contains: Norethisterone Acetate BP 15mg | 1 Tablet | M/s Synokem Pharmaceuticals Ltd. / M/s Obsurge Biotech Ltd. | 19.20 |
15. | Atorvastatin & Clopidogrel Capsules | Each Hard Gelatin Capsule Contains: Atorvastatin Calcium IP eq to Atorvastatin 40mg (As green coloured spherical pellets) Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As two brown coloured film coated tablets Each containing 37.5mg Clopidogrel Tablets) | 1 Capsule | M/s Windlas Biotech Limited. / M/s Mankind Pharma Ltd. | 30.74 |
16. | Ivermectin & Albendazole Tablets | Each uncoated Chewable tablet contains: Ivermectin IP 6mg Albendazole IP 400mg | 1 Tablet | M/s Next Wave (India) / M/s Mankind Prime Labs Pvt. Ltd. | 22.52 |
17. | Aceclofenac, Paracetamol & Thiocolchicoside tablets | Each film coated tablet contains: Aceclofenac IP 100mg Paracetamol IP 325mg Thiocolchicoside IP 4mg | 1 Tablet | M/s Synokem Pharmaceuticals Ltd. / M/s Troikaa Pharmaceuticals Ltd. | 16.27 |
18. | Etoricoxib & Paracetamol Tablets | Each Film Coated tablet contains: Etoricoxib IP 60 mg Paracetamol IP 325 mg | 1 Tablet | M/s Haelwood Laboratories Pvt. Ltd. / M/s Eris Healthcare Pvt. Ltd. | 7.67 |
19. | Metformin Hydrochloride prolonged- release and Glimepiride Tablets | Each uncoated bilayered tablet contains: Glimepiride IP 1 mg Metformin Hydrochloride IP 500 mg (as prolonged-release form) | 1 Tablet | M/s Akum Drugs & Pharmaceuticals Limited/M/s German Remedies Pharmaceuticals Pvt. Ltd. | 6.93 |
20. | Ivermectin & Albendazole Oral Suspension | Each 5 ml contains: Ivermectin IP 1.5 mg Albendazole IP 200 mg | 1 ML | M/s Next Wave (India) / M/s Mankind Prime Labs Pvt. Ltd. | 2.20 |
21. | Cilnidipine & Telmisartan tablets | Each film coated tablet contains: Cilnidipine IP 10mg Telmisartan IP 40 mg | 1 Tablet | M/s Mediforce Healthcare Pvt. Ltd./ M/s Mankind Prime Labs Pvt. Ltd. | 9.92 |
22. | Nimesulide & Paracetamol tablets | Each uncoated tablet contains: Nimesulide BP 100mg Paracetamol IP 325 mg | 1 Tablet | M/s Softdeal Pharmaceutical Private Limited | 4.27 |
23. | Travoprost & Timolol Maleate Eye Drops | Each ml contains: Travoprost IP 40 mcg Timolol Maleate eq. to Timolol IP 5 mg | 1 ML | M/s East African (India) Overseas/ M/s Alkem Laboratories Limited | 123.68 |
24. | Dorzolamide & Timolol Eye Drops | Composition: Dorzolamide Hydrochloride IP eq. to Dorzolamide 2% w/v Timolol Maleate eq. to Timolol IP 0.5 % w/v Water for Injection | 1 ML | M/s East African (India) Overseas/ M/s Alkem Laboratories Limited | 63.67 |
25. | Brimonidine Tartrate & Timolol Maleate Ophthalmic Solution | Each ml contains: Brimonidine Tartrate IP 2 mg Timolol Maleate eq. to Timolol IP 5 mg | 1ML | M/s East African (India) Overseas/ M/s Alkem Laboratories Limited | 49.04 |
26. | Atorvastatin & Clopidogrel Tablets | Each uncoated bilayered tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 20 mg Clopidogrel Bisulphate eq. to Clopidogrel IP 75 mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Limited/M/s German Remedies Pharmaceuticals Pvt. Ltd. | 17.17 |
27. | Telmisartan & Chlorthalidone Tablets | Each film coated tablet contains: Telmisartan IP 80mg Chlorthalidone IP 12.5mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Limited/M/s Abbott Healthcare Pvt. Ltd. | 10.55 |
28. | Voglibose, Glimepiride and Metformin Hydrochloride (sustained release)Tablets | Each uncoated bilayered tablet contains: Voglibose IP 0.2mg Glimepiride IP 2mg Metformin Hydrochloride IP 1000mg (as sustained release form) | 1 Tablet | M/s Swiss Garnier Genexiaa Sciences Pvt Ltd. / M/s Mankind Pharma Ltd. | 13.31 |
29. | Vitamin D3 Oral Solution | Each 5ml contains: Cholecalciferol IP (In nano Droplet form) 60000IU | 1 ML | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Mankind Pharma Limited | 13.94 |
30. | Vitamin D3 Oral Solution | Each 5ml contains: Cholecalciferol IP (In nano Droplet form) 60000IU | 1 ML | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Mankind Prime Labs Pvt. Ltd. | 13.94 |
31. | Calcium & Vitamin D3 Suspension | Each 5ml contains: 625mg Calcium Carbonate from an Organic Source (Oyster Shell) eq. to Elemental Calcium 250mg Vitamin D3 IP 125IU | 1 ML | M/s Shivalik Remedies Pvt. Ltd. / M/s Mankind Prime Labs Pvt. Ltd. | 0.51 |
32. | Voglibose, Glimepiride and Metformin Hydrochloride (sustained release) Tablets | Each uncoated bilayered tablet contains: Voglibose IP 0.2mg Glimepiride IP 1mg Metformin Hydrochloride IP 1000mg (as sustained release form) | 1 Tablet | M/s Swiss Garnier Genexiaa Sciences Pvt Ltd. / M/s Mankind Pharma Ltd | 11.43 |
33. | Diclofenac Diethylamine, Methyl Salicylate, Linseed Oil & Menthol Tropical Spray | Composition: Diclofenac Diethylamine IP 1.16% w/w eq. to Diclofenac Sodium IP 1% w/w Virgin Linseed Oil BP 3% w/w Methyl Salicylate IP 10% w/w Menthol IP 5% w/w | 1GM | M/s Pontika Aerotech Ltd./M/s Zuventus Healthcare Ltd. | 2.69 |
34. | Diclofenac Diethylamine, Linseed Oil, Methyl Salicylate & Menthol Gel | Composition: Diclofenac Diethylamine IP 1.16% w/w eq. to Diclofenac Sodium IP 1% w/w Virgin Linseed Oil(Oleum Lini) BP 3% w/w Methyl Salicylate IP 10% w/w Menthol IP 5% w/w | 1GM | M/s Nanz Med Science Pharma Pvt. Ltd./M/s Zuventus Healthcare Ltd. | 2.83 |
35. | Tramadol & Paracetamol Tablets | Each film coated tablet contains: Tramadol Hydrochloride IP37.5mg Paracetamol IP 325mg | 1 Tablet | M/s Hab Pharmaceuticals & Research Limited / M/s German Remedies Pharmaceuticals Private Limited | 8.35 |
36. | Telmisartan & Amlodipine Tablets | Each uncoated bilayered tablet contains: Telmisartan IP 40mg Amlodipine Besylate IP eq. to Amlodipine 5mg | 1 Tablet | M/s Indchemie Health Specialities Pvt. Ltd. | 9.49 |
37. | Telmisartan & Metoprolol Succinate ER Tablets | Each film coated bilayered tablet contains: Telmisartan IP 40mg Metoprolol Succinate IP eq. to Metoprolol Tartrate 50mg (as Extended Release form) | 1 Tablet | M/s Akum Drugs & Pharmaceuticals Limited/M/s German Remedies Pharmaceuticals Pvt. Ltd. | 13.66 |
38. | Telmisartan + Hydrochlorothiaz ide Tablets | Each uncoated bilayered tablet contains: Telmisartan IP 40mg Hydrochlorothiazide IP 12.50mg | 1 Tablet | M/s Indchemie Health Specialities Pvt. Ltd. | 9.95 |
39. | Paracetamol & Chlorzoxazone Tablets | Each uncoated tablet contains: Paracetamol IP 500mg Chlorzoxazone USP 250mg | 1 Tablet | M/s The Madras Pharmaceuticals/M/ s Sun Pharmaceutical Industries Ltd. | 10.31 |
40. | Diclofenac Diethylamine, Methyl Salicylate, Menthol & Absolute Alcohol Topical Spray | Composition: Diclofenac Diethylamine IP 2.32% w/v eq. to Diclofenac Sodium IP 2% w/v Methyl Salicylate IP 10% w/v Menthol IP 5% w/v Absolute Alcohol IP 10% v/v | 1 GM | M/s Pontika Aerotrch Limited / M/s Mankind Pharma Ltd. | 3.22 |
41. | Vildagliptin + Metformin Hydrochloride Tablet | Each film coated tablet contains: Vildagliptin 50mg Metformin Hydrochloride IP 500mg | 1 Tablet | M/s Associated Biotech / M/s Unistretch Pharmaceuticals Pvt. Ltd. | 6.75 |
42. | Vildagliptin + Metformin Hydrochloride Tablet | Each film-coated tablet contains: Vildagliptin IP 50mg Metformin Hydrochloride IP 1000mg | 1 Tablet | M/s Windlas Biotech Limited / M/s Mankind Prime Labs Pvt. Lttd. | 7.60 |
43. | Vildagliptin (as Immediate release) and Metformin Hydrochloride (as sustained release) Tablets | Each uncoated bilayer tablets contains: Vildagliptin IP (as Immediate release) 50mg Metformin Hydrochloride IP (as sustained release) 1000mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd. M/s German Remedies Pharmaceuticals Pvt. Ltd. | 8.06 |
44. | Vildagliptin (as Immediate release) and Metformin Hydrochloride (as sustained release) Tablets | Each uncoated bilared tablets contains: Vildagliptin IP (as Immediate release) 50mg Metformin Hydrochloride IP (as sustained release) 500mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd. M/s German Remedies Pharmaceuticals Pvt. Ltd. | 7.21 |
Besides these, the authority has also revised the retail price of Hetero Labs and Emcure Pharma's Darunavir plus Ritonavir tablet at Rs 212.91.
| Sl. No. | Name of the Formulation | Dosage form & Strength | Unit | Retail Price (Rs.) | DoP (i) Review no. & Date (ii) Letter no. and Date | Existing SO number & date | Manufacturer & Marketing Company respectively |
| (1) | (2) | (3) | (4) | (5) | (6) | (7) | (8) |
| 1. | Darunavir + Ritonavir tablet | Each film coated tablet contains: Darunavir Ethanolate eq. to Darunavir 800mg, Ritonavir IP 100mg Tablet | 1 Tablet | 212.91 | (i)31015/16/2019- Pricing dated 25.06.2021 (ii)31015/16/2019- Pricing (E-14046) dated 05.04.2022 | 4062(E) dated 08.11.2019 (at Sl. No. 25) | M/s Hetero Labs Limited / M/s Emcure Pharmaceuticals Ltd. |
Note:
To view the official notices, click on the links below:
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.